MARKET

APGE

Apogee Therapeutics Inc
APGE
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-32.0413
-
8.52
10,223,142,366.45
*News On Apogee Therapeutics Inc. (APGE) Now Under ABBV
Dow Jones · 09/03 21:09
ABBV Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?
NASDAQ · 09/03 15:02
State Street SPDR S&P Biotech ETF Experiences Big Inflow
NASDAQ · 09/03 14:55
AbbVie seals $11B acquisition of Apogee Therapeutics
Seeking Alpha · 09/03 13:24
Apogee Therapeutics Completes Merger and Plans Nasdaq Delisting
TipRanks · 09/03 13:16
AbbVie completes acquisition of Apogee for $135.11 per share in cash
TipRanks · 09/03 12:41
*AbbVie Expects Acquisition to Negatively Impact Adj EPS by 14c in 2026 (Partial Year) >ABBV
Dow Jones · 09/03 12:38
*AbbVie Expects Acquisition to Negatively Impact Adj EPS by About 46c in 2027, With Accretion Beginning in 2032 >ABBV
Dow Jones · 09/03 12:38
More

Webull offers Apogee Therapeutics Inc stock information, including NASDAQ: APGE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APGE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APGE stock methods without spending real money on the virtual paper trading platform.